1[1]Marti HP, McNeil L, Davies M. Homology cloning of rat 72 KD type Ⅳ collagenase:cytokine and second messanger indueibility in glomerular mescngial cells. Biochem J, 1993,291:441～446.
2[2]Marti HP, McNeil L, Thomas G Molecular characterization of a low molecular weight matrix metalloproteinase secreted by glomerulous mesangial cells as Pump-1. Biochem J, 1992,285:899 ～ 905.
3[3]Magnatti P. Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney Int, 1995,49 :S12 ～ S14.
4[4]Nagase H. Activation mechanisms of matrix metalloproteinases. BiolChem, 1997,378:151 ～ 160.
5[5]Nerlov C ,Blasi F,Johnsen M. Esssential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene,1991,6:1583 ～ 1592.
6[6]Hanemasijer R, Koolwijk P ,LeClercq L. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha,interleukin 1 and phorbol ester. Biochem J,1993,296(Pt 3) :803 ～809.
7[7]Leehey DJ,Song RH, Alavi N, et al. Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes, 1995,44:929 ～ 935.
8[8]Shanklaod SJ, Ly H,Thai K ,et al. Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats. J Am Soc Nephrol, 1996,7:97 ～ 104.
9[9]DelPrete D, Anglani F, Forino M. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia,1997,40:1449 ～ 1454.
10[10]Suzuki D ,Miyazaki M ,Jinde K, et al. In situ hybridization studies of metalloproteinase-3 ,tissue inhibitor of metalloproteinase Ⅰ and type Ⅳ collagen in diabetic nephropathy K dney Int, 997,52:111 ～ 119
